**No new pandemic has emerged in 2026, supporting the market's 89.5% implied probability for "No."** As of mid-June, global surveillance shows only localized outbreaks without sustained international human-to-human transmission meeting WHO pandemic criteria. Ongoing Ebola (Bundibugyo virus) clusters in the Democratic Republic of the Congo and Uganda remain regionally contained, while a May hantavirus outbreak linked to cruise ship travel produced limited cases with no evidence of efficient airborne or community spread. Current conditions reflect improved post-COVID preparedness, including the 2025 WHO Pandemic Agreement and strengthened International Health Regulations, which enhance early detection through genomic sequencing, wastewater monitoring, and multi-pathogen platforms. COVID-19 transmission is stable or declining in most U.S. states per CDC Rt estimates, with very low emergency department visits, and no novel respiratory viruses show signs of rapid escalation. Historical zoonotic spillover models estimate roughly 2.5–3.3% annual risk of a COVID-scale event, consistent with trader consensus that 2026 will likely avoid crossing the threshold for a new pandemic declaration. Key upcoming factors include continued monitoring of influenza A subtypes, filoviruses, and mosquito-borne threats, alongside routine WHO outbreak reports; any rapid model shift or confirmed superspreader event could alter odds, but present data indicate containment remains probable through year-end.